Why use the Xfect RNA Transfection Reagent to transfect siRNA oligos?
- It's effective—get better knockdown than with the leading competitor
- It's easy—no optimization necessary
- It's nontoxic—Xfect won't kill your cells
Effective gene silencing using transfected siRNA oligos
Having good siRNA oligos is not enough if you can't deliver those siRNAs effectively since your experiment will fail. The Xfect RNA Transfection Reagent was developed to maintain a very low cytotoxicity profile while delivering high rates of gene silencing. The ratio of oligo to reagent is pre-optimized, so you don't have to waste time on preliminary experiments. Transfecting siRNA with Xfect RNA Transfection Reagent has been shown to result in successful knockdown, e.g., a 95% decrease in luciferase activity (Figure 1).
Figure 1. Successful knockdown in primary cells and cell lines treated with siRNA. HeLa cells (2.0 x 105), Human Dermal Fibroblasts (NHDF) cells (6.0 x 104), and Mesenchymal Stem Cells (MSCs) (5.0 x 104) were plated in 12-well plates and transfected with 50 pmol of siRNA against luciferase using Xfect RNA Transfection Reagent. All three cell types were also transfected with 1 µg of pCMV-Luc using the Xfect Transfection Reagent. Luciferase assays were performed 48 hours post-transfection. For control samples, cells were transfected with pCMV-Luc but without the siRNA. We observed a dramatic (>95%) decrease in luciferase activity in all the cells treated with siRNA.